Showing results (811-820 of 826) with videos related to

Sort By:
Pageof 83
Cancers|February 15, 2022
Long-Term Follow-Up of Elderly Patients with Acute Myeloid Leukemia Treated with Decitabine: A Real-World Study of the Apulian Hematological NetworkMichelina Dargenio, Giuseppe Tarantini, Nicola Cascavilla, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 10, 2018
Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' projectFrancesca Palandri, Giulia Benevolo, Alessandra Iurlo, et al.
Haematologica|May 30, 2020
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913Sabina Chiaretti, Monica Messina, Irene Della Starza, et al.
European Journal of Haematology|September 16, 2025
Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter StudyMaria Carmen Martorelli, Novella Pugliese, Maria Di Perna, et al.
Annals of Hematology|October 10, 2025
Single versus double autologous stem cell transplantation and lenalidomide maintenance versus no maintenance therapy in newly-diagnosed patients with multiple myeloma: a real-life, vintage snapshot after twenty-three years from the Rete Ematologica PuglieseNicola Di Renzo, Emanuela Resta, Michelina Dargenio, et al.
Giornale Italiano Di Cardiologia (2006)|February 3, 2025
[ANMCO/GISE/SICOA Consensus document: Role of coronary computed tomography angiography in chronic coronary syndromes]Pasquale Guarini, Francesco Saia, Carlo Tedeschi, et al.
European Journal of Cancer (Oxford, England : 1990)|April 30, 2016
Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trialsMassimo Gentile, Katja Zirlik, Stefania Ciolli, et al.
Hematological Oncology|July 19, 2022
NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphomaMaria Carmela Vegliante, Saveria Mazzara, Gian Maria Zaccaria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2018
Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissueS Ciavarella, M C Vegliante, M Fabbri, et al.
Nature Communications|May 3, 2024
A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrationsIngrid M Saldana-Guerrero, Luis F Montano-Gutierrez, Katy Boswell, et al.
Pageof 83